search
PR Newswire
Trends
- 1ModifyHealth Expands Executive Team to Accelerate Growth●ModifyHealth Expands Executive Team to Accelerate Growth and Impact
ModifyHealth, a nutrition-focused healthcare company, announced an expansion of its executive team aimed at accelerating growth and increasing its impact. The announcement, issued via PR Newswire, describes the leadership additions as part of the company's push to scale its medically tailored meal services. Details on the specific new hires were not provided in the headline.
- 2Former Pfizer CSO Bill Sessa Named Chair of Isomab's Scientific Advisory Board●Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, previously Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The appointment was announced via PR Newswire. It signals Isomab's effort to strengthen its scientific leadership as it advances its development programs, bringing senior pharmaceutical industry experience to the company's advisory structure.
- 3Investor Deadline Looms in York Space Systems Securities Fraud Suit●York Space Legal Alert: York Space Systems (YSS) Investors who Lost Money are Notified of the Upcoming Deadline in the Ongoing Securities Fraud Class Action
York Space Systems investors who suffered losses are being reminded of an upcoming deadline in a securities fraud class action against the company. A legal notice published via PR Newswire alerts shareholders to the deadline for seeking lead plaintiff status or participating in the ongoing litigation. No details of the alleged fraud or the deadline date were included in the notice.